Singapore Paincare Holdings Limited (SGX:FRQ)
Singapore
· Delayed Price · Currency is SGD 0.1060
+0.0040 (3.92%)
At close: Apr 29, 2025
SGXC:FRQ Income Statement
Financials in millions SGD. Fiscal year is July - June.
Millions SGD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2017 - 2019 |
| Operating Revenue | 26.91 | 22.08 | 18.84 | 10.96 | 9.65 | Upgrade
|
| Other Revenue | 0.58 | 0.34 | 0.35 | 0.4 | 0.33 | Upgrade
|
| Revenue | 27.49 | 22.42 | 19.19 | 11.35 | 9.97 | Upgrade
|
| Revenue Growth (YoY) | 22.58% | 16.85% | 69.05% | 13.82% | 150.57% | Upgrade
|
| Cost of Revenue | 17.87 | 13.56 | 10.39 | 5.97 | 5 | Upgrade
|
| Gross Profit | 9.62 | 8.86 | 8.8 | 5.38 | 4.97 | Upgrade
|
| Selling, General & Admin | 0.3 | 0.21 | 1.25 | 0.11 | 0.05 | Upgrade
|
| Other Operating Expenses | 3.97 | 4.67 | 1.02 | 2.22 | 2.37 | Upgrade
|
| Operating Expenses | 6.77 | 6.76 | 3.41 | 3.06 | 3.2 | Upgrade
|
| Operating Income | 2.86 | 2.1 | 5.39 | 2.31 | 1.77 | Upgrade
|
| Interest Expense | -0.5 | -0.21 | -0.15 | -0.23 | -0.18 | Upgrade
|
| Interest & Investment Income | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Earnings From Equity Investments | 0.81 | 0.1 | 0.4 | 0.28 | 0.26 | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | 0.63 | 0.23 | - | Upgrade
|
| EBT Excluding Unusual Items | 3.17 | 1.99 | 6.28 | 2.6 | 1.85 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | -0.73 | -1.11 | - | - | Upgrade
|
| Asset Writedown | -0.2 | - | - | - | - | Upgrade
|
| Other Unusual Items | -0.01 | - | 0.04 | 0.02 | 0.55 | Upgrade
|
| Pretax Income | 2.95 | 1.26 | 5.21 | 2.62 | 2.4 | Upgrade
|
| Income Tax Expense | 0.58 | 1.29 | 0.88 | 0.46 | 0.52 | Upgrade
|
| Earnings From Continuing Operations | 2.38 | -0.03 | 4.33 | 2.16 | 1.88 | Upgrade
|
| Minority Interest in Earnings | -0.41 | -0.64 | -0.43 | 0.04 | - | Upgrade
|
| Net Income | 1.97 | -0.67 | 3.9 | 2.2 | 1.88 | Upgrade
|
| Net Income to Common | 1.97 | -0.67 | 3.9 | 2.2 | 1.88 | Upgrade
|
| Net Income Growth | - | - | 77.33% | 17.16% | 49.55% | Upgrade
|
| Shares Outstanding (Basic) | 171 | 175 | 180 | 169 | 61 | Upgrade
|
| Shares Outstanding (Diluted) | 171 | 175 | 180 | 169 | 80 | Upgrade
|
| Shares Change (YoY) | -2.31% | -2.55% | 6.01% | 112.82% | 1546.55% | Upgrade
|
| EPS (Basic) | 0.01 | -0.00 | 0.02 | 0.01 | 0.03 | Upgrade
|
| EPS (Diluted) | 0.01 | -0.00 | 0.02 | 0.01 | 0.02 | Upgrade
|
| EPS Growth | - | - | 67.15% | -45.88% | -90.76% | Upgrade
|
| Free Cash Flow | 2.94 | 3.68 | 5.9 | 2.76 | 2.39 | Upgrade
|
| Free Cash Flow Per Share | 0.02 | 0.02 | 0.03 | 0.02 | 0.03 | Upgrade
|
| Dividend Per Share | - | 0.004 | 0.012 | 0.007 | 0.007 | Upgrade
|
| Dividend Growth | - | -70.83% | 60.00% | 7.14% | - | Upgrade
|
| Gross Margin | 35.00% | 39.53% | 45.85% | 47.38% | 49.85% | Upgrade
|
| Operating Margin | 10.39% | 9.38% | 28.09% | 20.39% | 17.72% | Upgrade
|
| Profit Margin | 7.15% | -2.97% | 20.33% | 19.38% | 18.83% | Upgrade
|
| Free Cash Flow Margin | 10.70% | 16.43% | 30.75% | 24.30% | 24.01% | Upgrade
|
| EBITDA | 3.4 | 2.46 | 5.57 | 2.4 | 1.98 | Upgrade
|
| EBITDA Margin | 12.36% | 10.98% | 29.03% | 21.13% | 19.81% | Upgrade
|
| D&A For EBITDA | 0.54 | 0.36 | 0.18 | 0.08 | 0.21 | Upgrade
|
| EBIT | 2.86 | 2.1 | 5.39 | 2.31 | 1.77 | Upgrade
|
| EBIT Margin | 10.39% | 9.38% | 28.09% | 20.39% | 17.72% | Upgrade
|
| Effective Tax Rate | 19.48% | 102.39% | 16.95% | 17.59% | 21.82% | Upgrade
|
| Advertising Expenses | 0.06 | 0.03 | 1.11 | 0.06 | 0.01 | Upgrade
|
Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.